MYO18B and hepatocellular carcinoma: As shown in Table 1, statistical analysis revealed that no significant association was found in age, gender, grade, pathologic-N and pathologic-M and MYO18B expression (P > 0.05), while MYO18B expression was remarkably correlated with pathologic-stage (P = 0.025) and pathologic-T (P = 0.014), implying that high expression of MYO18B might be involved in the progression of HCC.